Why do firms need to innovate, change, and have in place quality risk management strategies? 


Evidence suggests that the likelihood of pandemics or other natural disasters has increased over the past century because of increased global travel and integration, urbanization, changes in land use, and greater exploitation of the natural environment. It is probable that these trends likely will continue and will intensify.

In this whitepaper, you will explore: 

∗  Why bringing back the supply of chemicals and APIs to individual nations will be extremely difficult.

∗ Why firms need to innovate, change, and have in place quality risk management strategies.

∗  What the risk assessment should look at to determine needs such as safety stock, building reactive capacity, automation, cross-training, etc.

∗ Why companies should focus on manufacturing locations known to have financial stability, full supply chain capabilities and have established Contingency Plans.

∗ Why the components of a good contingency plan should include the following: Scenarios, Triggers, Response, Who to Inform, Key Responsibilities, and a Timeline.


At Bora, we understand that your product supply is critical and planning for the supply of your products in many types of disasters is a key responsibility of your CDMO partner. Want to learn how we at Bora think about the current COVID-19 situation and how we plan for contingencies, then fill out the form to the right to download our comprehensive whitepaper, "Pharmaceutical outsourcing and planning in a COVID world."